Clinical Trial Update: Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating maraviroc as an immunomodulatory approach in HIV-infected individuals on antiretroviral therapy with immunologic failure has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV Infection | Phase 4 | Status: COMPLETED | Results posted: 2012-07-18